Found 0 matching trials
Endoscopic Ultrasound Shear Wave Elastography in Patients With Non-alcoholic Fatty Liver Disease N/A The goal of this observation study is to assess whether endoscopic ultrasou...
Show More Location
Brigham and Women's Hospital
Learn More & Join Trial
Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 Diabetes PHASE4 The purpose of this study is to evaluate whether exenatide is superior to i...
Show More Location
Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University
Learn More & Join Trial
Screening for Chronic Liver Diseases in General Population NA Improving the care of patients with liver diseases in primary care and will...
Show More Status
Active Not Recruiting
Location
CHU de Montpellier
Learn More & Join Trial
Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes N/A The aim of this study is to assess the prevalence of nonalcoholic fatty liv...
Show More Status
Active Not Recruiting
Location
Joslin Diabetes Center
Learn More & Join Trial
Prevalence, Incidence and Characteristics of NAFLD/NASH in Type 1 Diabetes Mellitus N/A Nonalcoholic fatty liver disease (NAFLD) is a condition characterized by in...
Show More Location
Antwerp University Hospital
Learn More & Join Trial
Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers NA Prospective screening study at Odense University Hospital to assess the eff...
Show More Location
Department of Gastroenterology and Hepatology, Odense University Hospital
Learn More & Join Trial
Non-Invasive MASLD Diagnosis & T2D Remission Biomarkers N/A The goal of this observational study is to prospectively develop and valida...
Show More Status
Active Not Recruiting
Location
Alhakeem Radiology Center
Learn More & Join Trial
The Franciscus Obesity NASH Study N/A The purpose of this study is to evaluate Non-Alcoholic Fatty Liver Disease ...
Show More Status
Active Not Recruiting
Location
Franciscus Gasthuis
Learn More & Join Trial
Characteristics of NAFLD Among Type 2 Diabetes Patients NA Type 2 diabetes patients have a high risk of developing NAFLD. This was con...
Show More Status
Active Not Recruiting
Location
Ziekenhuis Oost-Limburg
Learn More & Join Trial
A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE) PHASE3 A 52-Week, Multi-center, Open-label, Active Treatment Extension Study to Ev...
Show More Status
Active Not Recruiting
Location
Central Research Associates
Learn More & Join Trial